Essex Woodlands Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Essex Woodlands Management’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	–	Sell	-5,815,940	Closed	-$89M	–	11
2014 Q2	$89M	Hold	5,815,940	–	–	18.51%	2
2014 Q1	$85.1M	Hold	5,815,940	–	–	21.65%	2
2013 Q4	$42.1M	Hold	5,815,940	–	–	21.17%	2
2013 Q3	$18M	Hold	5,815,940	–	–	11.89%	4
2013 Q2	$13.1M	Buy	+5,815,940	New	+$14M	10.07%	4

Other funds holding HZNP

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

VAM

Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return

MRM

Michael R. Murphy $255M AUM 0.87% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return

KCM

Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Essex Woodlands Management's HZNP Position: Q3 2014 in Review

Essex Woodlands Management sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q3 2014, closing a stake of 5,815,940 shares — an estimated $89M sold.

Essex Woodlands Management first reported a position in HZNP in Q2 2013 and held it in 5 quarters. The position peaked at $89M in Q2 2014. 120 funds tracked by Wall St. Rank hold HZNP as of Q3 2014.

Essex Woodlands Management reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q3 2014 after selling out during the quarter.
Essex Woodlands Management sold 5,815,940 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q3 2014, an estimated $89M.
Essex Woodlands Management first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q2 2013 and held it in 5 quarters.
Essex Woodlands Management's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $89M in Q2 2014.
120 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q3 2014.

Based on Essex Woodlands Management's 13F filing for Q3 2014, filed 14 Nov 2014.